There is something particularly demoralizing about flooding through a pad every hour and still being told your bloodwork is 'basically fine.' A ferritin of 11 is not fine. It is a body running on fumes. If the fatigue feels completely disproportionate to everything else going on, iron is the first place worth looking — not after the bleeding is sorted, but right now, alongside it.
Learn more about Rose →In a normal cycle, a well-timed progesterone surge after ovulation stabilizes the uterine lining and signals it to shed in an orderly, limited way. In perimenopause, ovulation becomes erratic and progesterone output drops inconsistently, leaving estrogen to stimulate the lining unopposed for longer stretches — the result is a thicker, more vascular lining that sheds heavily and sometimes for longer than a week. This is not a coincidence or bad luck; it is a direct consequence of the hormonal chaos that defines early perimenopause, and it sets the biological stage for blood loss that compounds month after month.
Most standard blood panels flag anemia only when hemoglobin drops below a threshold, but the body depletes ferritin — its iron storage protein — long before hemoglobin falls. A woman can have hemoglobin in the normal range and a ferritin of 10 or 12 ng/mL, which represents critically depleted iron stores that impair cellular energy production, thyroid function, and neurotransmitter synthesis. Because many labs list the normal ferritin range as 12–150 ng/mL and mark anything above 12 as acceptable, a woman with a ferritin of 13 may be told she is fine when she is functionally iron deficient and deteriorating cycle by cycle.
A typical menstrual cycle involves a blood loss of roughly 30–40 mL; heavy menstrual bleeding is clinically defined as more than 80 mL per cycle, though many women in perimenopause lose considerably more. The average diet provides only 1–2 mg of absorbed iron per day, while a single heavy perimenopausal cycle can remove 10–30 mg of elemental iron from the body's stores in just a few days. When cycles arrive every three weeks instead of four — another common perimenopause pattern — the deficit compounds faster than the gut can replenish it through food alone, even in women eating iron-rich diets.
Estrogen fluctuation causes its own brand of fatigue, largely mediated through disrupted sleep and serotonin dysregulation, but iron deficiency fatigue operates through an entirely separate and more fundamental mechanism: without adequate iron, mitochondria cannot produce ATP efficiently, meaning every cell in the body is running on a reduced energy supply. The result is a bone-deep, unrestorative exhaustion that sleep does not fix, because the problem is not in the sleep architecture but in cellular energy metabolism itself. When iron deficiency and hormonal disruption stack on top of each other, the fatigue becomes severe enough that many women begin investigating serious illness — and the real cause is missed entirely.
Iron is a required cofactor for the synthesis of dopamine, serotonin, and norepinephrine — the neurotransmitters that govern focus, working memory, and mental clarity. When ferritin is low, neurotransmitter production becomes rate-limited, and the cognitive symptoms that result — word-finding difficulty, inability to concentrate, a sense of mental static — closely mirror those of hormonal brain fog but do not fully resolve with hormone therapy alone. Women who attribute all of their cognitive symptoms to estrogen decline and never address iron may find that their brain fog is only partially improved even after HRT, because they are treating one half of a two-part problem.
When blood carries less oxygen due to depleted hemoglobin or inadequate iron for red cell function, the heart compensates by beating faster and harder to maintain oxygen delivery to tissues — a mechanism that produces palpitations, a pounding sensation, or episodes of a racing heart at rest. This symptom is frequently attributed to estrogen-driven autonomic nervous system changes in perimenopause, which also cause palpitations, leading to an easy misattribution that leaves the iron deficiency unaddressed. Cardiac workups come back unremarkable, women are reassured, and the actual driver — insufficient iron — continues to deplete with each successive heavy period.
Restless legs syndrome (RLS) has a well-established association with low iron stores, specifically low ferritin, because iron is essential for dopaminergic function in the brain regions that regulate sensorimotor activity during sleep. Perimenopause is an independent risk period for RLS onset, and when iron deficiency is layered on top of the hormonal transition, the severity and frequency of RLS symptoms increase significantly compared to either factor alone. Many women are prescribed sleep aids or told their RLS is just another menopause symptom, when repleting iron to an optimal ferritin level — generally considered above 50–75 ng/mL for RLS — could substantially reduce or resolve the symptoms.
The standard clinical response to heavy perimenopausal bleeding typically involves hormonal management — progestins, combined oral contraceptives, a levonorgestrel IUD, or referral for endometrial assessment — all of which address the source of the blood loss without assessing what that blood loss has already cost the body in iron stores. A systematic review of primary care management of heavy menstrual bleeding found that iron status was infrequently assessed and even less frequently treated, despite iron deficiency being the predictable downstream consequence of prolonged heavy periods. Treating the faucet without draining the flood is the central clinical failure that leaves women symptomatic for months or years longer than necessary.
Replenishing severely depleted iron stores through standard oral supplementation can take three to six months even in women with good gut absorption, and in women with gut inflammation, low stomach acid (common in midlife), or who are taking proton pump inhibitors, oral iron may absorb so poorly that stores barely move despite consistent supplementation. Intravenous iron infusion can replenish stores in a single session with near-complete bioavailability, and it is both safe and well-tolerated, yet it remains dramatically underutilized in outpatient settings for perimenopausal women despite meeting clinical criteria for its use. Women who have been told to 'just take iron tablets' for six months while still flooding every few weeks deserve to know that a faster, more effective option exists and that asking for a referral to discuss IV iron is entirely reasonable.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.